3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546

NCT04727138 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Oncology

Interventions

DRUG: EXS21546 Powder for Oral Suspension
DRUG: EXS21546 Granule in Capsule
OTHER: Midazolam
OTHER: Food Effect
OTHER: Placebo Powder for Oral Suspension

Sponsor

Exscientia AI Limited

Collaborators

[object Object]